A. Aksan Et Al. , "Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.46, no.7, pp.705-706, 2017
Aksan, A. Et Al. 2017. Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.46, no.7 , 705-706.
Aksan, A., Isik, H., Radeke, H. H., Dignass, A., & Stein, J., (2017). Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.46, no.7, 705-706.
Aksan, A. Et Al. "Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.46, no.7, 705-706, 2017
Aksan, A. Et Al. "Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.46, no.7, pp.705-706, 2017
Aksan, A. Et Al. (2017) . "Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.46, no.7, pp.705-706.
@article{article, author={A. Aksan Et Al. }, title={Letter: the importance of dosing and baseline haemoglobin when establishing the relative efficacy of intravenous iron therapies-authors' reply}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2017, pages={705-706} }